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Abstract
Interpretation of allelic copy measurements at polymorphic markers in cancer samples
presents distinctive challenges and opportunities. Due to frequent gross chromoso-
mal alterations occurring in cancer (aneuploidy), many genomic regions are present
at homologus-allele imbalance. Within such regions, the unequal contribution of al-
leles at heterozygous markers allows for direct phasing of the haplotype derived from
each individual parent. In addition, genome-wide estimates of homologue specific copy-
ratios (HSCRs) are important for interpretation of the cancer genome in terms of fixed
integral copy-numbers. We describe HAPSEG, a probabilistic method to interpret bi-
allelic marker data in cancer samples. HAPSEG operates by partitioning the genome
into segments of distinct copy number and modeling the four distinct genotypes in each
segment. We describe general methods for fitting these models to data which are suit-
able for both SNP microarrays and massively parallel sequencing data. In addition, we
demonstrate a specially tailored error-model for interpretation of systematic variations
arising in microarray platforms. The ability to directly determine haplotypes from
cancer samples represents an opportunity to expand reference panels of phased chro-
mosomes, which may have general interest in various population genetic applications.
In addition, this property may be exploited to interrogate the relationship between
germline risk and cancer phenotype with greater sensitivity than is possible using un-
phased genotype. Finally, we exploit the statistical dependency of phased genotypes
to enable the fitting of more elaborate sample-level error-model parameters, allowing
more accurate estimation of HSCRs in cancer samples.
Author Summary
The human genome typically exists in two copies of each chromosome, with one copy, or homologue
derived from either parent. One of the most fundamental hallmarks of human cancers is their
tendency to have aneuploid genomes, that is, unbalanced copy-number alterations in the genetic
material at various blocks of the normal human genome. This often results in unequal contributions
of the homologues derived from either parent to the genomes of cancer cells. Estimation of the
precise contribution of each homologue in a DNA sample obtained from cancer tissue is crucial
to understand the genetic alterations occurring specifically in the cancer cells. Such estimation
requires the identification and interpretation of alterations in the genetic sequence of each homologue,
such as they appear in the cancer sample, which contains a mixture of DNA derived from both
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cancerous and normal cells. We have developed a statistical method to accurately model the resulting
data, producing summarizations of the information from hundreds of thousands of data points into
hundreds of segments, describing the concentration of both homologues for large genomic regions
of equal copy-number. In addition, we show that the tendency of cancer samples to be aneuploid
may be exploited to attribute contiguous chromosomal blocks of genetic variation to one or the
other homologue, representing the contribution of a single parent. Because they can help reduce the
dimensionality of the data, such summarizations will be useful to further understand the interaction
between inherited genetic variation and cancer development.
Introduction
The genomes of human cancer cells frequently harbor copy-number alterations, ranging from focal
gain and loss of small regions to widespread chromosomal aneuploidy [1], [2], in many cases exacer-
bated by DNA ploidy increases followed by predominant attrition of the fixed DNA in the evolving
somatic clone [3]. Allelic analysis of cancer genomes offers several advantages in analysis of cancer
genomes [4], [5]. Detection of genomic regions with fixed somatic loss of heterozygosity - (LOH)
helps identify recessively inactivated tumor suppressors, carrying mutations on the retained allele
[6]. In particular, allelic measurements are required for detection of copy-neutral LOH, which may
occur either due to compensatory gain of the retained alleles, or by homologous recombination. Fi-
nally, genome-wide HSCR estimates provide the foundation for inference of tumor-nuclei percentage,
cancer-genome ploidy, and integral allelic copy-numbers [7], [8], [9], [3].
Human genomes are normally diploid, with one haploid genome inherited from each parent
(although tetraploid cells are also involved in physiological processes [10].) As a result of widespread
chromosomal aneuploidy, many genomic regions are in homologos-allele imbalance, with the two
homologues fixed at unequal copy-numbers within the somatic clone [3]. Methods for genotyping
diploid samples are unsuitable for analysis of aneuploid cancer samples. For example, discovery of
both germline and somatic point-mutations in cancer samples using massively paralell sequencing
typically requires analysis of paired cancer-normal DNAs [11], [12]. For SNP microarrays, probes for
each SNP allele are calibrated using diploid control samples [13], making genotype calls unreliable
in aneuploid samples [14].
Accurate estimation of homologue-specific DNA concentrations in tumor samples is challenging
due to substantial marker-level noise occurring on a background of complex biases related to the
genotypes, sequence context, allelic copy-numbers at which loci are observed. The particular mani-
festation of these factors in the resulting data depends on physical properties of the technology used.
Development of explicit generative models describing these effects in particular samples can provide
greater sensitivity to detect true alterations in the underlying cancer genome. We extend previous
physically grounded error models for gene expression microarrays [15], [16] for use with Affymetrix
SNP arrays, facilitating our ability to estimate HSCRs in multiple cancer-derived datasets.
Early work with SNP microarrays demonstrated the feasibility of allelic cancer-genome analysis
[17, 18, 4], setting the stage for development of methods to detect allele-specific amplification [19],
and LOH in unpaired samples [20]. Development of high-resolution Affymetrix SNP6.0 microarrays
was enabled by the development of a method to accurately calibrate allelic probes, allowing for
highly accurate genotyping without the need for mismatch probes [13]. These calibrations became
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the basis for modern cancer total copy-ratio analysis using these arrays [21], [22], [23].
The development of methods for allelic analysis in cancer samples has been further pursued to
identify genomic regions of LOH [24], and as part of solutions to the tumor purity/ploidy problem
using Illumina bead-arrays [7], [8], and in Affymetrix SNP6.0 microarrays [25], [14], [9]. Our view
is that this problem is best treated separately, allowing for detailed treatment of the HSCR problem
and facilitating comparison of various methods specifically addressing this problem [26], [27], [28].
We present a novel computational method, HAPSEG, for accurate estimation of haplotype-
specific DNA copy-ratios (HSCRs), offering several specific advantages over existing methods: (i)
implementation of an advanced error model tailored to the basic physics of Affymetrix SNP microar-
ray measurements; (ii) Internal recomputation of genomic segmentation using error-model fit; (iii)
utilization of LD information from phased haplotype panels [29], improving inference of genotypes
by exploiting statistical dependencies between the genotypes of adjacent markers, and improving
HSCR estimation.
We present a novel demonstration of direct haplotype phasing using allelic imbalances in cancer-
tissue samples. These are of interest to further characterize the influence of germline risk in cancer
development. In addition, this capability may be used to generate densley typed reference panels of
phased chromosomes for use with imputation of rare alleles in whole exome sequencing
Results
Method overview
Consider a defined set of polymorphic bi-allelic markers (SNPs), for which data proportional to the
concentration of each allele (channels a and b) has been generated. For microarray data, the set
of SNPs is fixed by the array design. We define the copy-ratio as the ratio of allelic concentration
in a cancer-derived DNA sample to that of the haploid locus concentration in an equivalent DNA
aliquot derived from diploid cells. The copy-ratio of a given allele depends on both the (germline)
genotype and on the concentration in the cancer-derived DNA of the homologue on which it resides
(the location).
Calibration is the process by which SNP measurements are standardized to copy-ratios. The
specific manner in which calibration is performed depends upon the measurement technology being
considered (e.g. microarray or sequencing). After calibration, the expected a and b values for a SNP
in a diploid sample (at a region of 2 copies) are (0,2), (1,1), or (2,0), corresponding to genotypes BB,
AB/BA, and AA, respectively. These values are observed with substantial noise, the distribution of
which depends upon the measurement platform being used.
Because DNA copy-number is expected to be locally constant along the genome, superior HSCR
estimates can be obtained by pooling datapoints within segments of constant total copy-ratio. For
the purpose of initializing such a segmentation, calibrated signal from the a and b channels is added
together genome-wide to produce copy-ratio estimates independently of marker genotypes. These
values are input to the a segmentation algorithm, (e.g. CBS [30]), which fits a piecewise constant
regression function to these values with respect to their location along the reference genome.
Figure 1 shows an example of HAPSEG on a cancer sample with pervasive allelic imbalance.
Calibrated allelic copy-ratio estimates for each marker (fig. 1a) were modeled using HAPSEG,
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which performed haploid genotyping and segmentation (fig. 1b). The resulting HSCR estimates
are summarized at segmental level (fig 1c), revealing discrete levels occurring at regular copy-ratio
intervals, consistent with fixed SCNAs in the cancer clone (fig 1d). These estimates formed the basis
of a large-scale inference of absolute copy-numbers in cancer [3].
We assume that, within such a segment, the copy-ratios of both haplotypes will nearly always
remain constant. Violations from this assumption would correspond to coincident breakpoints,
with compensatory changes in the homologous copy numbers such that the total is unchanged.
We note that such cases are theoretically possible (homologous recombination), and have been
previously reported using related methods [28]; we leave the treatment of such alterations to future
development.
A maximum of two distinct homologous copy-ratios can exist in a given segment, and the sum
of A and B alleles at (germline) heterozygous sites must equal the number of A and B alleles at
homozygous AA and BB sites, respectively. The allelic concentration ratios therefore generally corre-
spond to four clusters the possible phased genotype of each SNP. The locations of these components,
denoted µAAi ,µABi ,µBAi ,µBBi , are specified by two free parameters: the total copy-ratio τi, and
the difference of homologous copy-ratios, denoted δi. The locations of the homozygous components
are then:
µAAi = (0, τi) , µBBi = (τi, 0) . (1)
The locations of the heterozygous components are:
µABi =
(
τi − δi
2
,
τi + δi
2
)
, µBAi =
(
τi + δi
2
,
τi − δi
2
)
. (2)
As segments approach allelic-balance (δi → 0), the two heterozygous clusters become superimposed,
with the natural corollary that no information is provided regarding the phase of SNPs in that
segment (as when genotyping diploid samples). To model observed allelic data, we represent the
four possible phased genotypes using a mixture model with components for each genotype {AA, AB,
BA, BB}. Figure 2 demonstrates HSCR estimation on 3 example segments (from a single sample,)
at differing homologous copy-numbers (fig 2a,b). The relationship between homologous imbalance
and phased genotyping is demonstrated (fig 2c-h).
The calibrated data for M measured markers, X, are a 2 × M matrix of bi-allelic (haploid)
copy-ratio point estimates. Segmentations of X are denoted by S, which specify partitions of X
into N successive matrices X1...N . For each segment i, Xi has dimension 2 ×Mi, where Mi refers
to the number of SNPs in the segment. The model parameter C represents the 4 phased genotypes
of SNPs X. Denote by Xij the a and b channels for SNP j in segment i, and by Cij the genotype
of SNP j. Prior information about the genotype of each SNP may be available from population
allele-frequencies, from the analysis of a paired-normal sample, or from phased haplotype panels,
and is represented as G.
The conditional distribution of X, representing the mapping from segment locations µi to proba-
bility densities over observed Xi, is denoted P (Xi|µi,Θ), where Θ represents the set of sample-level
parameters representing specific sources of experimental fluctuation. Estimation of Θ at the sample-
level increases our power to fit realistically complex error-models without the risk of over-fitting small
segments. The function P and parameters Θ are specific to the measurement platform in use. We
developed a novel error-model for Affymetrix SNP microarrays (Methods) and applied it throughout.
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We specify the probability density of an observed point, conditional on g as:
P (Xij |Cij = g, δi, τi,Θ) ≡ P
(
Xij |µig,Θ
)
. (3)
The complete likelihood of segment i is therefore:
Li (Xi|δi, τi,Θ,G) =
Mi∏
j=1
Zij , (4)
where Zij denotes the complete likelihood of SNP j:
Zij =
4∑
g=1
P (Xij |Cij = g, δi, τi,Θ)P (Cij = g|G) . (5)
The full sample-likelihood is:
Lf (X|δ, τ ,Θ,S,G) =
∏
i∈S
Li (Xi|δi, τi,Θ,S,G) . (6)
We implemented model-fitting using general numerical optimizations which are independent of the
specific likelihood; support for alternate measurement platforms may be added by implementing
an appropriate density for P (Xi|µi,Θ). We describe an general algorithm for joint estimation of
sample-level error-model parameters Θ and segmental allelic copy-ratios δ, τ , denoted C*, allowing
updates of these parameters based on {X, Sˆ,G}: {Θˆ, δˆ, τˆ} = C*
(
Θˆ(n)|X, Sˆ,G
)
.
We use the C*algorithm to iteratively update the genomic segmentation S, genotype probabilities
G, sample error-model parameters Θ , and HSCR locations δ, τ .
Method HAPSEG:
1. Initialize: Compute Sˆ(1) from X. Set Θ(0), δ(0), τ (0),G(0).
2. Fit error-model / segment-locations: {Θˆ(1), δˆ(1), τˆ (1)} = C*
(
Θ(0)|X, Sˆ(1),G(0)
)
.
3. Refine segmentation: Compute Sˆ(2) from {Θˆ(1), δˆ(1), τˆ (1)} Estimation of Θˆ(1) allows for
more sensitive and specific evaluation of proposed segmental breakpoints. Consider a pair of
adjacent segments in the reference genome. Because the initial segmentation Sˆ(1) may have
introduced a spurious breakpoint, we develop a probabilistic criterion for their merger using
Bayesian model comparison (Methods).
4. Update: {Θˆ(2), δˆ(2), τˆ (2)} = C*
(
Θˆ(1)|X, Sˆ(2),G(0)
)
.
5. Haploid genotype estimation: compute Cˆ(1) from P (C|X, Θˆ, δˆ, τˆ ,G(0)). For a segment i,
posterior distributions Cˆi are computed for each SNP j as follows:
Cˆij =
1
Zij
P
(
Xij |Cij = g, δˆi, τˆi, Θˆ
)
P
(
g|G(0)
)
, (7)
where Zij is computed as in (5). Cˆ
(1) contains the probability distribution of the haploid
genotypes, with the phase information provided by homologous copy-imbalance in the somatic
clone.
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6. Reconciliation of phased genotype estimates with reference panels: compute Gˆ(1)
from Cˆ(1), D, m.
This procedure examines the evidence for the phased genotypes in a given segment in a panel
of phased reference chromosomes characterizing population diversity of haplotypes Consor-
tium:2010en. This is accomplished using the statistical program BEAGLE [31] to phase diploid
genotypes estimates computed from Cˆ(1). This procedure utilizes phased panels D, and an
estimate of the genetic recombination rate m to compute a maximum-likelihood estimate of
phase. HAPSEG then identifies and corrects ’switch-errors’ in this phasing by reconciling the
estimates with those based on homologous imbalance (Cˆ(1)). The phasing ability of HAPSEG
was validated by examining the local concordance with maximum likelihood phase estimates
produced via BEAGLE [31], a statistical method based on a population reference-panel of
phased chromosomes (fig 3). We demonstrate that phase estimates produced by BEAGLE are
locally concordant with those implied by HAPSEG, but that switch-errors tend to occur at
regions of high recombination rate (fig 3a,b).
7. Final estimates:
{Θˆ, δˆ, τˆ} = C*
(
Θˆ(2)|X, Sˆ(2), Gˆ(1)
)
(8)
Cˆ(2) = P
(
Cijk|Xij , δˆi, τˆi, Θˆ,G(1)
)
(9)
8. Standard error of location estimates. With the Hessian Ai as in eq.(14), standard errors
on the segment locations are:
σδi =
√∣∣A−1i11 ∣∣, στi = √∣∣A−1i22 ∣∣.
This approximation is valid given that the posterior distribution of δ and τ is multivariate
normal.
Affymetrix error model. Following a classic microarray error-model [15] we consider the
observed calibrated signal X to be distributed according to:
X = µeη + , (10)
η ∼ N (0, ση),  ∼ N (0, σ),
where µ represents the true copy-ratio, η and  represent multiplicative and additive errors, respec-
tively. Importantly, this allows for specifying cluster variance as a function of the mean, without
the need to fit additional segment-level variance parameters, as in [28].
We generalized this error model to the two-dimensional case appropriate for fitting two-channel
microarray data (Methods, eq. (17)). Because an explicit formula for likelihood calculations could
not be obtained, we used an approximation whereby a transformation is applied to the data, after
which its distribution becomes approximately bi-variate Gaussian. Specifically, we extended the
variance stabilization technique described for the one-dimensional case [32] to the 2D error model,
accounting for additional observed correlations in heterozygous SNP clusters, which were presumed
to arise from the PCR amplification. Additional parameters are included in Θ taking into account
attenuation and background fluctuation (Methods). The quality of the model-fit to the marker-
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level data is shown in figure 4, demonstrating that much of the variation in the data is accurately
captured.
Discussion
We have demonstrated the ability of HAPSEG to accurately estimate haplotype-specific DNA con-
centrations in tumor samples, including those for which no patient-matched normal sample exists.
We demonstrated the utility of HSCR estimates from HAPSEG to estimate tumor purity, ploidy,
and absolute copy-numbers using ABSOLUTE [3]. By factorizing general inference methods from
platform-specific error models, greater generality was achieved, allowing us to easily adapt HAPSEG
to the analysis of massively parallel sequencing data. Although promising results have been obtained
from whole-exome hybrid capture sequencing (WES)[33] data (not shown), further development is
needed to derive calibrated copy-estimates from multiplexed WES using bar-coded reads.
In addition to providing accurate estimates of haplotype-specific copy-ratios, HAPSEG can pro-
duce partially phased haplotypes by exploiting the widespread allelic-imbalance common in aneuploid
cancer genomes, without the need for methods based on phased reference panels. This will have
several applications in cancer genetics, such as establishing compound heterozygosity of germline
alleles. In addition, when used with sequencing data, long-range haplotyping using HAPSEG will
aid reconstruction of complete somatic karyotype and history of aberrations transforming from the
diploid state[34]. Furthermore, these methods may aid detection of specific SCNAs subject to allelic
bias in cancer [35, 36, 8].
The availability of partially phased genotypes will allow improvements in panel-based imputa-
tion methods, which attempt to model observed diploid genotypes as a mosaic of phased reference
haplotypes [37], [38], [39], [40], [31], (reviewed[41]). Optimal exploitation of will require extension
of these methods to handle partially phased genotype data containing variable gaps (due to somatic
allele-balance.)
Similar considerations apply to admixture mapping, whereby long-range phasing may be inferred
by differences in parental allele-frequency along the genome, due to recent mixing of outbred pop-
ulations [42], [43]. The phased homologues provided by HAPSEG, each of which is derived from
a single parent, will allow for more sensitive detection of recent admixture, possibly supporting
mapping with less divergent populations than permitted in the purely diploid case. Since admixture
inferences allow for inter-chromosomal phasing of homologues, they may be of interest in the analysis
of germline risk loci.
Long-range haplotyping has utility to uncover interactions between germline and somatic genetics
in cancer. Examples include variants at the 8q24 locus, affecting inherited risk of development of
multiple cancer types [42], and later shown to interact with MYC [44]. Furthermore, these methods
may facilitate identification of additional germline alleles mechanistically predisposed to somatic
alteration in cancer, such as JAK2 in myeloproliferative neoplasms [45]. In contrast, to the above
examples, the genetic basis by which EGFR mutations in lung adenocarcinoma occur predominately
in female non-smoking patients of East Asian ethnicity [46] remains unclear.
As whole-genome sequencing of aneuploid cancer samples becomes increasingly routine, directed
long-range haplotyping using HAPSEG will increase the available panels of densely genotyped chro-
mosomes, without the need for genotyping parent-child trios. This resembles the precedent of geno-
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
hd
l:1
01
01
/n
pr
e.
20
11
.6
49
4.
1 
: P
os
te
d 
5 
O
ct
 2
01
1
typing uniparental-disomic samples derived from complete hydatidiform moles [47], which formed
an important component of the phased Japanese HAPMAP panel [48]. HAPSEG generalizes this
requirement to allow direct phasing from homologous imbalance, extending the samples on which it
may be applied to tens of thousands of cancer samples [49].
Long-range haplotyping is an important technique for human population genetics, with wide
ranging applications including understanding haplotype diversity and genetic recombination rates
[29], illuminating recent positive selection in the human lineage [50] and human history [51].
Partially phased genotyping by analysis of cancer-derived DNA using HAPSEG represents a novel
technique to obtain such data. This may be particularly useful in the study of poorly characterized
populations, for which phased reference panels do not exist, and for which parent-child trio data
may be impossible to obtain. In such cases, this strategy may present a cost-effective alternative to
recently described molecular methods for long-range haplotyping [52], [53].
Methods
Algorithm C*
C* uses the data, segmentation S, and genotype priors G to update estimates of the sample error-
model Θ and segment locations {δ, τ}. This is accomplished by iterating two conditional updates
until convergence of Lf :
1. Conditional update of locations {δ, τ}:
∀i,
{
δ
(t+1)
i , τ
(t+1)
i
}
= argmax
{δi,τi}
logLi
(
Xi|δi, τi,Θ(t), Sˆ,G
)
(11)
2. Conditional update of sample error-model Θ. Θ is a vector of platform-specific param-
eters upon which conditional updates are performed serially. We found that the results are
insensitive to ordering, and suppress indexing:
Θ(t+1) = argmax
Θ
logLf
(
X|δ(t), τ (t),Θ, Sˆ,G
)
P (Θ). (12)
Note the superscripts (t) above denote the internal iterations of the C*algorithm.
3. Stop if the full likelihood Lf does not change significantly.
Probabilistic segment merging
Let H0 and H1 denote the seperate and merged segment hypotheses. In order to compare the
evidence supporting each model, we compute an approximation to the Bayesian evidence (Laplace)
by approximating the normalizing constant of the posterior distribution P (δi, τi|Xi, Θˆ). If the
posterior is multivariate Gaussian, the normalization constant may be calculated from the likelihood
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and curvature at the mode:
Ev(Xi) =
∫
δi
∫
τi
Li(Xi|δi, τi, Θˆ,G(0)) (13)
' Lˆi ×
∣∣∣∣det Ai2pi
∣∣∣∣−1/2 × (5/2)−2, (14)
where Lˆi denotes the maximum likelihood (at δˆi, τˆi), and Ai = −∇∇ logLi(Xi|δi, τi, Θˆ) denote the
Hessian matrix around the mode of a segment location: {δˆi, τˆi}. We verified the accuracy of the
approximation using quadrature on a subset of segments (not shown).
The constant third term gives the volume of the domain: δi × τi. Note that the first and
second-two terms correspond to the ’Best fit likelihood’ × ’Occam factor’ formulation of Evidence,
as described in [54].
Following Bayes’ rule: P (H|Xi) ∝ P (Xi|H)P (H), we compute the Bayes factor BF(H0):
P (H0|X1,2)
P (H1|X12) =
Ev(X1)Ev(X2)
Ev(X12)
. (15)
Our experience suggests that the cancer genome is often heavily over-segmented using the initial
segmentation Sˆ(1) described above. Adjacent segments are therefore merged if BF(H0) < 1×10−10.
BF(H0) is computed for all breakpoints in Sˆ(1) and segments are merged greedily by joining the
adjactent pair with the lowest BF(H0) value. The merge-probability for any breakpoints adjacent
to the resulting combined segment are computed at each step. The procedure is finished when no
pairs exist with BF(H0) below the threshold, resulting in a refined segmentation Sˆ(2). We note
that the Bayes factor defined above could equivalently be applied to accept or reject novel proposed
breakpoints in S. We leave the development of an efficient method to identify valid breakpoints to
the future.
Reconciliation of phased genotype estimates with reference panels
1. Compute diploid genotype estimates dˆ from haploid estimates Cˆ(1) by collapsing (marginaliz-
ing) the two heterozygous clusters.
2. Compute the maximum likelihood statsitical phasing of d using BEAGLE [31]:
Cˆ(B) = BEAGLE(dˆ,D,m)
If evidence exists for the haploytype configurations Cˆ(1) as a mosaic of phased chromosomes
in D with recombination rate m, then these configurations will be present in Cˆ(B), up to
occasional spurious phase reversals (switch-errors), which are expected to occur at frequency
related to m.
3. Reconcile haploid estimates from allelic-imbalance Cˆ(1) with Cˆ(B) by allowing for occasional
switch-errors:
Gˆ(1) = Viterbi(Cˆ(1), Cˆ(B),Φm)
This is accomplished using the Viterbi algorithm, which finds the best path through adjacent-
marker phased-genotype probabilities Cˆ(1) such that they are concordant with Cˆ(B), with
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occasional switches to the phase-reversed Cˆ(−B) (obtained by swapping of the AB and BA
genotype probabilities). Switching dynamics are governed by the transition-probability matrix
Φm:
Φm =
(
0.9 0.1
0.1 0.9
)
.
Thus, switches between Cˆ(B) and Cˆ(−B) are expected to occur with marginal probability 0.1. We
note the adjusting the switch-error probability according to the recombination rate m would likely
be more sensitive, however these values appear to work well on our data (fig. 3). Upon termination,
Gˆ(1) contains updated knowledge about haploid genotypes C. If no phase information is implied in
Cˆ(1) (due to allelic balance), Gˆ(1) = Cˆ(B), since the phase of either configuration in Cˆ(1) will be
equally probable. Likewise, if Cˆ(1) reflects a spurious phasing from over-fitting the locations of a
given segment, then the switch probability 0.1 is not adequate to form a path with expected switches
at every other marker. In such cases, the locations will be corrected by recomputing the segment
HSCRs using Gˆ(1) = Cˆ(B).
Calibration
(Note: The remaining sections describe methods specific to SNP microarrays)
Calibration of Affymetrix SNP-array measurements was accomplished using the Birdseed algo-
rithm [13], which combines population allele-frequency estimates with location estimates on training
samples with known genotypes. These prior estimates are adjusted by Birdseed to fit data from
batches of samples. These adjusted location estimates are then used to define the three diploid
genotype hybridization-intensity clusters, with locations denoted IAA, IAB , IBB . A large amount
of measurement error is thought to arise from variability in the conditions under which the PCR
reaction is run. We therefore define batches of PCR (eg., 96-well plates for which the reactions
were run in parallel.) Calibrations are performed independently for each of such batches. Genotype
locations are estimated using only the normal (non-cancer) samples in the batch, which need not
be paired to the cancer samples. Because Birdseed jointly determines the genotypes of the normal
samples along with the locations of the genotype clusters for the batch, it is not necessary to use
controls with known genotypes. Because normal samples are essential for calibration, we generally
recommend that at least 10 such samples be included in each batch.
With the intensity of the 3 genotype-clusters determined by Birdseed, background and scale
parameters for the a and b channels of each probe-set can be obtained. The background for each
channel is estimated as the observed intensity corresponding to zero copies of that allele:
I0a = IBBa , I0b = IAAb .
The scale for each channel is estimated as the difference in observed intensities corresponding to one
and zero copies of that allele:
d1a = IABa − IBBa , d1b = IABb − IAAb .
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Calibrations of observed intensities in cancer samples are then computed as:
Xa =
Ia − I0a
d1a
, Xb =
Ib − I0b
d1b
. (16)
The calibrated signals may therefore be interpreted as ratios of the locus-concentration in the tumor-
sample to the concentration corresponding to 1 copy in a sample derived from diploid cells.
The above calibration procedure is strictly valid given linear responses throughout the domain
of locus-concentration. In fact, attenuation effects are observed for many probe-responses at locus-
concentrations corresponding to 2-copies / diploid cell, and become more pronounced with increasing
concentration. By performing calibration using only locus concentrations corresponding to 0 and 1
copy, we have sought to base our estimates on values from the linear response range in karyotypically
normal samples. Attenuation effects occurring in tumor samples are dealt with in a subsequent
section.
Following the procedure described above, we perform an additional probe-set level calibration
step designed to remove spurious correlation between the a and b channels arising due to cross-
hybridization. This procedure is described in a subsequent section.
Error model
Modern SNP microarrays measure on the order of 100-1000K polymorphic sites present in an input
DNA aliquot. Specifically, these arrays allow for the measurement of hybridization occurring be-
tween input DNA and substrate-bound oligonucleotides corresponding to each of two forms for each
polymorphic locus interrogated (an a and a b channel for each SNP). In ideal cases, the experimental
conditions under which the array is run result in hybridization proportional to the concentration
of the specific locus being interrogated, plus some unknown background (presumed to arise from
non-specific hybridization.)
The motivation for the model in eq. (10) stems from the consideration of two major noise sources
inherent in the measurement procedure. A molecule with concentration proportional to µ is subjected
to n rounds of PCR amplification, to yield 2n molecules. Assume n ∼ N (m,σm), then log(µ) ∼ N .
Hybridization of species to the microarray then results in measured signal X ∼ N (µeη, σ). The
distribution of X is therefore the convolution of a normal and a log-normal distribution, representing
the measurement of a process subject to multiplicative noise using a process (hybridization) subject
to additive noise.
Although the error-model of eq. 10 fits the observed data reasonably well, consistent positive
correlation is observed between the a and b channels of the heterozygous clusters AB and BA.
Furthermore, the magnitude of this correlation is directly proportional to σˆη (not shown). Noting
that the two alleles of any given SNP lie on restriction fragments that typically differ by a single
base, we surmise that any variations in PCR efficiency arising due to sequence composition are likely
to be shared. This phenomenon affects only the heterozygous clusters because, by definition, one
allele is absent for any homozygous SNP, and is not subject to PCR amplification. We therefore
generalize the error-model of equation 10 to the 2-dimensional case as follows:[
Xa
Xb
]
= α+
[
µae
ηa
µbe
ηb
]
+
[
a
b
]
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[
ηa
ηb
]
∼ N (0,Ση) ; Ση =
[
ση ρση
ρση ση
]
(17)
[
a
b
]
∼ N (0,Σ) ; Σ =
[
σ 0
0 σ
]
Note that the assumption of diagonal additive covariance (Σ) in the above equation is reasonable
only because of the calibration procedure which removes cross-hybridization signal prior to fitting
the model. This procedure is described in a subsequent section.
Attenuation
The heterozygous segment locations are overdetermined with respect to δ and τ (2). For each seg-
ment, 8 genotype-cluster coordinates are determined by two free parameters. Observed discrepancies
from these dependencies can be exploited for improved estimates of microarray attenuation.
As in [55], we adopt the Langmuir isothermal adsorption model [56] to deal with attenuation
effects observed as the concentration of a given hybridized species increases:
θ =
φC
1 + φC
,
where θ indicates the proportion of bound species (presumed to be equivalent to the observed
hybridization signal), C indicates the concentration of a particular species, and φ is a constant
related to the binding affinity of the species to the oligonucleotide probes targeting it. This model
has been previously shown to accurately model the attenuation characteristics of microarray probes
[16].
Due to the calibration procedure described in eq (16), the observed copy-ratio X is actually the
ratio of two isotherms:
X =
φCT
1 + φCT
/
φCN
1 + φCN
,
where CT and CN are proportional to concentration in the tumor and normal sample, respectively.
Let CR = CT /CN . Because CN is defined to be the hybridization intensity corresponding to 1 copy
for a given probe-set, we can rewrite the above equation as:
X =
CR(1 + φ)
(1 + CRφ)
.
We can then define a transformation of genotype-cluster coordinates:
g(µ) =
µ(1 + φ)
(1 + µφ)
(18)
This transformation is applied to the locations of the 4 genotype-clusters defined in equations 1, 2.
This ensures that the physical constraints defined by the model are compatible with the observed
data.
Noting that
lim
CR→∞
CR(1 + φ)
(1 + CRφ)
=
1 + φ
φ
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corresponds to the asymptotic saturation copy-ratio, m, gives a direct physical interpretation for
the value of φ; φ = 1m−1 .
Variance-stabilizing transformation
Following [32], we make use of a variance-stabilizing transformation h, such that
h(x) ' h(µ) + h; h ∼ N (0, σh), (19)
where σh is constant over the domain of X. Writing the variance of X as a function of the mean µ :
var(X) = v(µ), a general form for h can be expressed as [57]:
h(x) =
∫ x 1√
v(u)
du.
The specific form of h(x) for use with the error-model defined by eq. (10) is derived in [32]:
h(x) = log
(
bx+
√
1 + bx2
)
(20)
= sinh−1(bx).
The transformation has a parameter b that is calculated from ση and σ as follows:
b =
√
eσ
2
η − 1
σ
. (21)
The transformed data, denoted X′, will have variance, denoted σ2h, approximately independent of
X, with
σh = σ
d
dx
h(x)|x=0 (22)
= σb.
Using simulated data, we verified that the approximation in eq. 19 is accurate for values of ση and
σ within the range of typical estimates (data not shown).
Likelihood calculation
We construct an approximation to the model defined in eq. (17) based on application of the variance-
stabilizing transformation (eq. 20) applied to both data channels. We use the scaled bivariate t-
distribution on the transformed data X′, which has an additional parameter ν ∈ Θ allowing excess
density in the tails.
P (Xij |µik,Θ) ≡ P (Xij |µik, ν,Σi)
=
1
2pi|Σi|1/2
(
1 + ν
(
X′ij − µ′ik
)T
Σ−1i (X
′
ij − µ′ik)
)−(ν/2+1)
|Jij |, (23)
where
X′ij = h(Xij),
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and
µ′ik = h(g(µik)),
with g and h given by eqns. 18 and 20, respectively. Define
X′ij =
[
X ′a
X ′b
]
,
The Jacobian of the transformation h is:
|Jij | =
∣∣∣∣∣∣
∂h(X′a)
∂X′a
∂h(X′a)
∂X′b
∂h(X′b)
∂X′a
∂h(X′b)
∂X′b
∣∣∣∣∣∣
=
∂h(X ′a)
∂X ′a
∂h(X ′b)
∂X ′b
=
b√
1 + (bX ′a)2
b√
1 + (bX ′b)2
,
where b and σh may be calculated from ση and σ via equations (21) and (22), respectively.
Introducing a sample-level parameter 0 < ρh <
3
4σ
2
h ∈ Θ, we approximate the covariance-matrix
of the transformed data in a given segment i as:
Σi =
[
σ2h sρh
sρh σ
2
h
]
, with s =
µikaµikb if µikaµikb < 11 otherwise.
Thus, the covariance is spherical for the homozygous clusters. The scaling of ρh by s provides a
consistent approximation to the covariance implied by eq. (17) for heterozygous clusters.
Substitution of eq. (23) into the generic form for P (Xij |µik,Θ) in eq. (3) completes the
specification of our HSCR estimation based on SNP microarray data. The sample-level error model
parameters which must be estimated from the data are: Θ = {σ, ση, ρh, ν, φ}.
Calibration of cross-hybridization effects
We develop a calibration step to remove allelic-crosstalk from copy-ratio data X in a SNP-specific
manner as follows. Starting with large collection of normal samples, genotyped using Birdseed
[13], we compute the cluster-centers for each genotype for each SNP. We attempt to estimate the
covariance matrix for each SNP, denoted Σi. We make use of the factorization Σ = SRS, where
R =
(
1 rAB
rAB 1
)
, S =
(
σ2 0
0 σ0
)
,
with rAB denoting the correlation between the A and B allele. σ0 and σ2 denote the standard-
deviation of genotype-cluster axes corresponding to 0 and 2 copies, respectively.
Because we are attempting to estimate a large number of parameters from data which may
be limited, we make use of a Bayesian regularization technique. Population priors describing the
distribution of scales and correlations are estimated from all SNPs, and these are then used to
compute the most probable (MP) estimates for each SNP. This follows standard use of a hierarchical
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model, as in [58].
We use scaled-inverse-χ2 prior distributions for σ0 and σ2, defined as follows:
Let X ∼ χ2(ν) and Y = σ
2ν
X
, then Y ∼ Scale-inv-χ2(ν, σ2).
We use a normal distribution for the Fisher-transform of rAB , zAB =
1
2 log
(
1+r
1−r
)
. We denote the
standard error of z as zσ =
1√
N−3 . We define population-level distributions on the SNP covariance
parameters as:
zAB ∼ N (piµz , piσz )
σ20 ∼ Scaled-Inverse-χ2(pis0 , piν0)
σ22 ∼ Scaled-Inverse-χ2(pis2 , piν2)
piµz and piσz are estimated via maximum likelihood from the calculated SNP correlation-coefficients.
The MP estimate of z is the mode of the posterior (Gaussian) distribution:
zˆMP =
piµz
pi2zσ
+ zˆMLz2σ
1
pi2zσ
+ 1z2σ
The MP estimate of r is the inverse of the Fisher transform on zˆMP:
rˆMP =
e2zˆMP − 1
e2zˆMP + 1
The posterior distribution for the scales σ0 and σ2 is:
σ20 |X ∼ Scaled-Inverse-χ2 (θσ, θν) ,
with
θ2σ =
piν0pi
2
s0 +Nσˆ
2
0ML
piν0 +N
, θν = piν0 +N
The posterior mode is therefore
σˆ0MP =
√
θνθ2σ
θν + 2
.
σˆ2MP is computed in a similar fashion.
We then construct the MP covariance matrix for each SNP:
ΣˆMP =
(
σˆ2MP 0
0 σˆ0MP
)(
1 rˆMP
rˆMP 1
)(
σˆ2MP 0
0 σˆ0MP
)
.
Denote the slope of the 1st eigen-vector of ΣˆMP as MˆBB . We construct an affine transformation
as follows:
T =
(
1 −MˆBB
0 1
)(
1 0
−MˆBB 1
)
.
The corrected data is then:
X’ = TX.
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Figure 1
Figure 1. Overview of analysis with HAPSEG a., Input data from an Affymetrix SNP
microarray hybridization. The calibrated allelic copy-ratios of A and B channels is shown for each
SNP vs. its genomic location. b., The data in (a), after processing with HAPSEG. SNPs are
colored according to their phased genotype: grey homozygous, red/blue heterozygous (phased),
purple heterozygous (unphased). The HSCR segmentation is indicated by green horizontal lines. c.,
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Summary of the data in (b), where the individual SNPs have been removed and each HSCR segment
is colored by the average phasability of the heterozygous SNPs from which it was estimated. d.,
A histogram summarizing the data in (c), by marginalizing over the genome. Although the HSCR
locations are independent between segments, only four discrete levels are apparent in the histogram.
These corresponding to fixed SCNAs fixed in the tumor sample, and are the basis for analysis with
ABSOLUTE [3].
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Figure 2. Examples of segmental HSCR inference by HAPSEG a., A tumor sample
with genome-wide HSCRs as inferred by HAPSEG, as in fig. 1c. b., Summary histogram of estimated
HSCR values, as in fig. 1d. c., e., g., Plots of calibrated A vs. B-allele copy-ratios for SNPs in three
genomic locations indicated in (a) (arrows). SNPs are colored by inferred (haploid) genotype, as in
fig. 1b. Contours denote the error-model fit for each genotype cluster: black - homozygous, green -
heterozygous. d.,f.,h., Plots of A and B-allele copy-ratios vs. genomic position for the segments in
(c,e,g). SNPs are colored as in (c,e,g). Horizontal lines denote genotype cluster locations, colored
as in (c,e,g) The heterozygous locations (HSCRs) correspond to the allelic copy-ratios in (a). c.,d.,
A segment (chr 7) at allelic balance, with equal copy-numbers of both homologues. No phase
information is available for heterozygous SNPs in this segment. e.,f., A segment (chr 2) at allelic
imbalance, with unequal homologous copy-numbers. Note that the SCNA affecting this segment
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was predicted to be subclonal by ABSOLUTE [3]. g.,h., A segment (chr 6) at more extreme allelic
imbalance. Note that the lower HSCR here corresponds to LOH in this tumor sample [3]; the DNA
contributing to the heterozygous alleles is derived from normal contaminating cells.
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Figure 3. Demonstration of direct haplotyping by homologous imbalance a.,b., Com-
parison of HAPSEG and BEAGLE phase in example segments. Top - Allelic copy-ratios of heterozy-
gous SNPs are shown at their genomic coordinates. Color indicates phase as estimated by HAPSEG
(Cˆ(2)), eq. (9). Grey horizontal lines indicate the HSCR estimates for the segment, estimated by
HAPSEG, eq. (8). Middle - The genetic recombination rate is plotted vs. the genome. Bottom - As
in (a), but replacing the HAPSEG phase estimates by those obtained using the statistical phasing
program BEAGLE [31]. Switch errors in the BEAGLE phasing, detected by HAPSEG, are indicated
by dotted vertical lines.
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Figure 4. Demonstration of error-model for Affymetrix SNP microarrays. a-d., The
fit of the error-model to marker-level data is shown in a single example segment. a., The histogram
summarizes the A and B channels for assayed markers within the genomic segment. The marginal
fit of the A/B marker copy-ratios is denoted by the green (het) and coral (het+hom) curves. b.,
Marker copy-ratios in (a) are shown separately for the A vs. B channel. Contours denote fit of
the error model to the 4 modeled genotype clusters, eq. (1), (2) (green - het, black - hom). c,d.,
as in a,b., but using the variance stabilizing transformation, eq. (20). Likelyhood calculations are
performed in this space using a bi-variate t distribution, eq. (23). Positive covariance of the A/B
channels is modeled in the heterozygous clusters (green), this aspect of the fit cannot be dispalyed
in one dimension, as in (a,c). Contours show the fit of this density to the data, as in (b), which were
derived by inverting the variance stabalizing transformation. We note that the covariance matrix
Σi in the density used here is fully determined by the segment HSCR locations, conditional on error
model parameters Θ, which are fit at the sample level, eq. (12). Only two degrees of freedom are
fit to the data specifically shown here, eq. (2). e-h., an additional example segment is shown, as in
a-d.
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